Cargando…

The harmful intestinal microbial community accumulates during DKD exacerbation and microbiome–metabolome combined validation in a mouse model

OBJECTIVE: Diabetic kidney disease (DKD) is one of the most prevalent complications of diabetes mellitus (DM) and is associated with gut microbial dysbiosis. We aim to build a diagnostic model to aid clinical practice and uncover a crucial harmful microbial community that contributes to DKD pathogen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shang, Jin, Cui, Wen, Guo, Ruixue, Zhang, Yiding, Wang, Peipei, Yu, Wei, Zheng, Xuejun, Wang, Ting, Dong, Yijun, Zhao, Jing, Ding, Suying, Xiao, Jing, Ren, Zhigang, Zhao, Zhanzheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9806430/ https://www.ncbi.nlm.nih.gov/pubmed/36601003 http://dx.doi.org/10.3389/fendo.2022.964389

Ejemplares similares

Gut Microbiome Analysis Can Be Used as a Noninvasive Diagnostic Tool and Plays an Essential Role in the Onset of Membranous Nephropathy
por: Shang, Jin, et al.
Publicado: (2022)

SGLT2 inhibitors suppress epithelial–mesenchymal transition in podocytes under diabetic conditions via downregulating the IGF1R/PI3K pathway
por: Guo, Ruixue, et al.
Publicado: (2022)

Corrigendum: SGLT2 inhibitors suppress epithelial-mesenchymal transition in podocytes under diabetic conditions via downregulating the IGF1R/PI3K pathway
por: Guo, Ruixue, et al.
Publicado: (2022)

The gut microbiome in differential diagnosis of diabetic kidney disease and membranous nephropathy
por: Yu, Wei, et al.
Publicado: (2020)

Sacubitril/Valsartan contributes to improving the diabetic kidney disease and regulating the gut microbiota in mice
por: Wang, Peipei, et al.
Publicado: (2022)

Generalizability of FIGARO‐DKD and FIDELIO‐DKD Trial Criteria to the US Population Eligible for Finerenone
por: Chiu, Nicholas, et al.
Publicado: (2022)

Update on Diabetic Kidney Disease (DKD): Focus on Non-Albuminuric DKD and Cardiovascular Risk
por: Scilletta, Sabrina, et al.
Publicado: (2023)

Untargeted serum metabolomics and tryptophan metabolism profiling in type 2 diabetic patients with diabetic glomerulopathy
por: Zhang, Fanliang, et al.
Publicado: (2021)

Development and validation of diagnostic models for immunoglobulin A nephropathy based on gut microbes
por: Dong, Yijun, et al.
Publicado: (2022)

Detection of DKD stage 1 and treatment are essential
por: Futrakul, Narisa, et al.
Publicado: (2018)

Network Pharmacology-Based Prediction of Mechanism of Shenzhuo Formula for Application to DKD
por: Wang, Xinmiao, et al.
Publicado: (2021)

Gut microbiota, key to unlocking the door of diabetic kidney disease
por: Wang, Peipei, et al.
Publicado: (2021)

Finerenone in Black Patients With Type 2 Diabetes and CKD: A Post hoc Analysis of the Pooled FIDELIO-DKD and FIGARO-DKD Trials
por: Flack, John M., et al.
Publicado: (2023)

The role of lncRNAs in regulation of DKD and diabetes-related cancer
por: Cheng, Yawei, et al.
Publicado: (2022)

Characterization and diagnostic value of the gut microbial composition in patients with minimal change disease
por: Zhang, Yiding, et al.
Publicado: (2022)

Role of Sphingolipid Signaling in Glomerular Diseases: Focus on DKD and FSGS
por: Mitrofanova, Alla, et al.
Publicado: (2020)

Kidney outcomes with finerenone: an analysis from the FIGARO-DKD study
por: Ruilope, Luis M, et al.
Publicado: (2022)

The Alteration in Composition and Function of Gut Microbiome in Patients with Type 2 Diabetes
por: Zhao, Xue, et al.
Publicado: (2020)

2DKD: a toolkit for content-based local image search
por: DeVille, Julian S., et al.
Publicado: (2020)

Virtual Patient Simulation in DKD: Successful Strategy for Improving Recognition and Management
por: Larkin, Amy, et al.
Publicado: (2021)

Identification and validation of key biomarkers for the early diagnosis of diabetic kidney disease
por: Yu, Wei, et al.
Publicado: (2022)

Construction of a Nomogram Discriminating Malignancy-Associated Membranous Nephropathy From Idiopathic Membranous Nephropathy: A Retrospective Study
por: Wang, Ting, et al.
Publicado: (2022)

Lessons learned from two randomized controlled trials: CITIES and STOP-DKD
por: Zullig, Leah L., et al.
Publicado: (2020)

ODP223 Metabolic efficacy of Very Low Carbohydrate Diet in DKD patients
por: Zainordin, Nur Aisyah, et al.
Publicado: (2022)

Both sexes develop DKD in the CD1 uninephrectomized streptozotocin mouse model
por: Trink, Jackie, et al.
Publicado: (2023)

Cost-Effectiveness of Canagliflozin Added to Standard of Care for Treating Diabetic Kidney Disease (DKD) in Patients with Type 2 Diabetes Mellitus (T2DM) in England: Estimates Using the CREDEM-DKD Model
por: Willis, Michael, et al.
Publicado: (2020)

The 2021–2022 position of Brazilian Diabetes Society on diabetic kidney disease (DKD) management: an evidence-based guideline to clinical practice. Screening and treatment of hyperglycemia, arterial hypertension, and dyslipidemia in the patient with DKD
por: de Sá, João Roberto, et al.
Publicado: (2022)

Development and validation of a discrimination model between primary PLA2R-negative membranous nephropathy and minimal change disease confirmed by renal biopsy
por: Wu, Feng, et al.
Publicado: (2021)

The Saudi Diabetic Kidney Disease study (Saudi-DKD): clinical characteristics and biochemical parameters
por: Al-Rubeaan, Khalid, et al.
Publicado: (2018)

Non-Albumin Proteinuria (NAP) as a Complementary Marker for Diabetic Kidney Disease (DKD)
por: Bae, Jaehyun, et al.
Publicado: (2021)

Combination of the gut microbiota and clinical indicators as a potential index for differentiating idiopathic membranous nephropathy and minimal change disease
por: Jiang, Yumin, et al.
Publicado: (2023)

Variation of Serum Uric Acid Is Associated With Gut Microbiota in Patients With Diabetes Mellitus
por: Zhang, Weifeng, et al.
Publicado: (2022)

Clinicopathologic characteristics and outcomes of lupus nephritis with positive antineutrophil cytoplasmic antibody
por: Wang, Shuai, et al.
Publicado: (2020)

Unfavourable intrauterine environment contributes to abnormal gut microbiome and metabolome in twins
por: Yang, Jing, et al.
Publicado: (2022)

Effects of liraglutide on extraglycemic inflammatory markers and renal hemodynamic parameters in diabetic kidney disease (DKD)
por: Song, Wenjuan, et al.
Publicado: (2023)

Renal insufficiency predicts worse prognosis in newly diagnosed IgD multiple myeloma patients
por: Yan, Ge, et al.
Publicado: (2022)

Diagnostic value of α1-MG and URBP in early diabetic renal impairment
por: Zhou, Yukun, et al.
Publicado: (2023)

Association between the nasopharyngeal microbiome and metabolome in patients with COVID-19
por: Liu, Jing, et al.
Publicado: (2021)

Characteristics of the sputum microbiome in COPD exacerbations and correlations between clinical indices
por: Su, Linfan, et al.
Publicado: (2022)

Oxidative Stress and NRF2/KEAP1/ARE Pathway in Diabetic Kidney Disease (DKD): New Perspectives
por: Tanase, Daniela Maria, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_abie06hpnq6pfl5ji74i7q1js5